Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
mifepristone
Pharma
FDA is moving forward with abortion pill safety study: WSJ
The FDA is investigating the safety of mifepristone, an initiative that could allow the administration to impose restrictions on its use, WSJ reports.
Kevin Dunleavy
Jun 5, 2026 11:06am
SCOTUS temporarily restores telehealth access to abortion pill
May 15, 2026 11:20am
Lawmakers, former FDA leaders and more rally behind mifepristone
May 8, 2026 3:14pm
Abortion pill producers ask SCOTUS to prevent online access ban
May 4, 2026 12:05pm
FDA takes close look at mifepristone REMS program
Sep 25, 2025 11:00am
Fierce Biotech
Biotech leaders urge FDA to not restrict abortion pill access
Jul 2, 2025 2:14pm
